Encap, when Livinloud wrote "Anything over 5mW is already illegal", you replied "Exactly", so I assumed you meant you agreed with the statement.
FDA's regulatory authority comes from 21 CFR 1040.10 and 1040.11. In these regulations, FDA is given power over all laser products -- the physical device or equipment -- but only over three laser uses: medical, demonstration (including laser light shows) and "surveying, leveling or alignment".
FDA has tried to increase its control of consumer lasers in two "waves".
The first wave, in the late 1980's, somehow convinced manufacturers and then the public that lasers used for pointing were demonstration and/or SLA lasers. I filed two Freedom of Information Act requests to find out what regulations, guidance, letters, internal memos or other documents stated this policy. So far, FDA has not come up with any documentation (!).
The second wave started around 2010 and as Encap states accelerated last year. The policy interpretation again is murky. There are two tacks that FDA has taken in this wave:
The trick is that if everyone believes FDA, or is cowed by them, or doesn't want to fight back, then -- just like what happened with laser pointers -- their claims will become "accepted reality" and everyone will start acting like FDA has the power -- which they don't -- over compact, handheld, battery-powered, portable lasers over 5 mW.
What is new in 2014 is that FDA isn't too sure of themselves. As I said before, if they already had this authority, they wouldn't have to have put out for public comment their May 5 proposal.
To conclude, there is a difference between the authority FDA is given in 21 CFR 1040.10 and 1040.11, and the authority they assert. 25 years ago, they slipped in their assertion about pointers, which everyone at the time assumed was correct. Now they are trying something similar with this SLA interpretation, to expand their authority. In my personal view as a private citizen, FDA is doing this based on a completely incorrect interpretation.
FDA's regulatory authority comes from 21 CFR 1040.10 and 1040.11. In these regulations, FDA is given power over all laser products -- the physical device or equipment -- but only over three laser uses: medical, demonstration (including laser light shows) and "surveying, leveling or alignment".
- As far as the product goes, as long as a manufacturer's product has the required safety features and paperwork, it can be sold and marketed in the U.S.
- The exception comes when a product is sold and marketed for medical, demonstration (laser show) or "surveying, leveling or alignment" (SLA) purposes. For the latter two, FDA can require that the product be under 5 mW.
FDA has tried to increase its control of consumer lasers in two "waves".
The first wave, in the late 1980's, somehow convinced manufacturers and then the public that lasers used for pointing were demonstration and/or SLA lasers. I filed two Freedom of Information Act requests to find out what regulations, guidance, letters, internal memos or other documents stated this policy. So far, FDA has not come up with any documentation (!).
The second wave started around 2010 and as Encap states accelerated last year. The policy interpretation again is murky. There are two tacks that FDA has taken in this wave:
- One tack is based on part of the 21 CFR 1040.10(b)(39) definition of an SLA laser: "Determining and delineating the form, extent, or position of a point, body, or area by taking angular measurement." FDA feels that because the word "point" is in there, any laser used for pointing is an SLA laser. (I disagree since the pointing is being done to highlight or call attention to something at a location. It is not being used to determine its position by taking angular measurement.)
- The other tack is newer. This is what FDA explicitly is stating in its May 5 proposal. This tack first claims that SLA lasers have features such as being compact, battery-powered, portable and handheld. Then by a breathtaking leap of logic, FDA concludes that lasers with these features are SLA lasers which they can control.
The trick is that if everyone believes FDA, or is cowed by them, or doesn't want to fight back, then -- just like what happened with laser pointers -- their claims will become "accepted reality" and everyone will start acting like FDA has the power -- which they don't -- over compact, handheld, battery-powered, portable lasers over 5 mW.
What is new in 2014 is that FDA isn't too sure of themselves. As I said before, if they already had this authority, they wouldn't have to have put out for public comment their May 5 proposal.
To conclude, there is a difference between the authority FDA is given in 21 CFR 1040.10 and 1040.11, and the authority they assert. 25 years ago, they slipped in their assertion about pointers, which everyone at the time assumed was correct. Now they are trying something similar with this SLA interpretation, to expand their authority. In my personal view as a private citizen, FDA is doing this based on a completely incorrect interpretation.